Publicacions en què col·labora amb Juan Tamargo Menéndez (24)

2016

  1. Vascular and central activation of peroxisome proliferator-activated receptor-β attenuates angiotensin II-induced hypertension: Role of RGS-5

    Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 1, pp. 151-163

2013

  1. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension

    Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631

2012

  1. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741

  2. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension

    Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79

2011

  1. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743

  2. Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: Role of NADPH oxidase

    Clinical Science, Vol. 120, Núm. 8, pp. 321-333

2010

  1. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats

    European Journal of Pharmacology, Vol. 627, Núm. 1-3, pp. 242-250

  2. Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation

    Atherosclerosis, Vol. 212, Núm. 1, pp. 78-85

2006

  1. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 24, Núm. 1, pp. 75-84

2002

  1. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats

    Journal of Hypertension, Vol. 20, Núm. 9, pp. 1843-1854

2001

  1. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats

    British Journal of Pharmacology, Vol. 133, Núm. 1, pp. 117-124

  2. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats

    Molecular and Cellular Biochemistry, Vol. 221, Núm. 1-2, pp. 155-160

  3. Flavonoids and cardiovascular diseases

    Studies in Natural Products Chemistry, Vol. 25, Núm. PART F, pp. 565-605

1999

  1. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction

    General Pharmacology, Vol. 32, Núm. 1, pp. 71-74

  2. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta

    British Journal of Pharmacology, Vol. 127, Núm. 7, pp. 1539-1544

1997

  1. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase

    European Journal of Pharmacology, Vol. 338, Núm. 1, pp. 25-33

  2. Effects of visnadine on rat isolated vascular smooth muscles

    Planta Medica, Vol. 63, Núm. 3, pp. 233-236

1995

  1. Vasodilator effects of visnagin in isolated rat vascular smooth muscle

    European Journal of Pharmacology, Vol. 286, Núm. 2, pp. 115-122

1994

  1. Inhibitory effects of quercetin and staurosporine on phasic contractions in rat vascular smooth muscle

    European Journal of Pharmacology, Vol. 262, Núm. 1-2, pp. 149-156

1993

  1. Aminophylline preferentially inhibits chloroethylclonidine-insensitive α-adrenoceptor-mediated contractions in rat aorta

    General Pharmacology, Vol. 24, Núm. 6, pp. 1359-1364